Chenkui Miao

960 total citations
43 papers, 576 citations indexed

About

Chenkui Miao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Chenkui Miao has authored 43 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Chenkui Miao's work include Renal cell carcinoma treatment (11 papers), Renal and related cancers (8 papers) and Ferroptosis and cancer prognosis (6 papers). Chenkui Miao is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Renal and related cancers (8 papers) and Ferroptosis and cancer prognosis (6 papers). Chenkui Miao collaborates with scholars based in China, United States and Singapore. Chenkui Miao's co-authors include Zengjun Wang, Aiming Xu, Jundong Zhu, Jianzhong Zhang, Chao Liang, Zengjun Wang, Shifeng Su, Bianjiang Liu, Shouyong Liu and Yibo Hua and has published in prestigious journals such as Cancer Research, Science Advances and Frontiers in Immunology.

In The Last Decade

Chenkui Miao

43 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenkui Miao China 15 357 209 129 110 79 43 576
Shifeng Su China 16 333 0.9× 133 0.6× 96 0.7× 113 1.0× 134 1.7× 34 534
Bong Ryoul Oh United States 13 463 1.3× 142 0.7× 167 1.3× 92 0.8× 88 1.1× 23 798
Charlotte Hill United Kingdom 11 270 0.8× 101 0.5× 238 1.8× 97 0.9× 91 1.2× 25 613
Marialaura Petroni Italy 16 424 1.2× 123 0.6× 54 0.4× 198 1.8× 49 0.6× 25 624
Yoko Ino Japan 13 282 0.8× 97 0.5× 52 0.4× 87 0.8× 44 0.6× 37 510
Wei Cang China 9 213 0.6× 159 0.8× 90 0.7× 100 0.9× 79 1.0× 19 470
Shigenori Furukawa Japan 12 162 0.5× 115 0.6× 59 0.5× 138 1.3× 54 0.7× 42 449
Roubini Zakopoulou Greece 10 358 1.0× 132 0.6× 62 0.5× 144 1.3× 49 0.6× 29 533
Zhaolei Cui China 15 311 0.9× 265 1.3× 69 0.5× 137 1.2× 52 0.7× 51 539
F. Alameda Spain 13 312 0.9× 117 0.6× 75 0.6× 268 2.4× 56 0.7× 28 711

Countries citing papers authored by Chenkui Miao

Since Specialization
Citations

This map shows the geographic impact of Chenkui Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenkui Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenkui Miao more than expected).

Fields of papers citing papers by Chenkui Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenkui Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenkui Miao. The network helps show where Chenkui Miao may publish in the future.

Co-authorship network of co-authors of Chenkui Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Chenkui Miao. A scholar is included among the top collaborators of Chenkui Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenkui Miao. Chenkui Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Baochao, et al.. (2025). O-GlcNAcylation of UBAP2L regulates stress granule formation and sunitinib resistance in clear cell renal cell carcinoma. Journal of Experimental & Clinical Cancer Research. 44(1). 273–273. 1 indexed citations
2.
Lü, Zhongwen, Yongsheng Pan, Songbo Wang, et al.. (2024). Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification. European journal of medical research. 29(1). 236–236. 1 indexed citations
3.
4.
Tsujino, Takuya, Tomoaki Takai, Chenkui Miao, et al.. (2023). Abstract PR014: Genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Cancer Research. 83(11_Supplement). PR014–PR014. 1 indexed citations
5.
6.
Miao, Chenkui, Takuya Tsujino, Tomoaki Takai, et al.. (2022). RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. Science Advances. 8(7). eabl9794–eabl9794. 25 indexed citations
7.
Wu, Jiajin, Chenkui Miao, Yuhao Wang, et al.. (2022). SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner. Journal of Translational Medicine. 20(1). 603–603. 9 indexed citations
8.
Miao, Chenkui, Chao Liang, Pu Li, et al.. (2021). TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner. Journal of Experimental & Clinical Cancer Research. 40(1). 195–195. 27 indexed citations
9.
Liu, Shouyong, Yi Wang, Chenkui Miao, Qianwei Xing, & Zengjun Wang. (2021). High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity. Cancer Cell International. 21(1). 140–140. 18 indexed citations
10.
Miao, Chenkui, Shouyong Liu, Jing Zhang, et al.. (2021). Clusterin suppresses invasion and metastasis of testicular seminoma by upregulating COL15a1. Molecular Therapy — Nucleic Acids. 26. 1336–1350. 10 indexed citations
11.
Miao, Chenkui, et al.. (2020). Effect of Enhanced Recovery After Surgery on Postoperative Recovery and Quality of Life in Patients Undergoing Laparoscopic Partial Nephrectomy. Frontiers in Oncology. 10. 513874–513874. 17 indexed citations
12.
Miao, Chenkui, et al.. (2020). Acinar with ductal and mucinous adenocarcinoma of prostate cancer complicated with lung metastasis: a case report and literature review. Annals of Palliative Medicine. 10(2). 2366–2370. 3 indexed citations
13.
Miao, Chenkui, et al.. (2020). Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 10. 1436–1436. 25 indexed citations
14.
Miao, Chenkui, Chao Liang, Yamin Wang, et al.. (2019). The management and composition of symptomatic seminal vesicle calculi: aetiological analysis and current research. British Journal of Urology. 125(2). 314–321. 5 indexed citations
15.
Zhu, Kai, Yao Zhang, Jundong Zhu, et al.. (2018). Testis Tumor of Ovarian Epithelial Type: A Rare Case. Urology. 115. e9–e10. 1 indexed citations
16.
Miao, Chenkui, Jie Yang, Jianxin Xue, et al.. (2018). Renal Ewing sarcoma/primitive neuroectodermal tumor in a pregnant woman who underwent robot-assisted laparoscopic nephrectomy: a case report and literature review. OncoTargets and Therapy. Volume 11. 6839–6843. 4 indexed citations
17.
Chen, Wei, Kai Zhao, Chenkui Miao, et al.. (2017). Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells. OncoTargets and Therapy. Volume 10. 1503–1512. 41 indexed citations
18.
Zhu, Jundong, Chenkui Miao, Shouyong Liu, et al.. (2017). Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies. OncoTargets and Therapy. Volume 10. 5805–5816. 8 indexed citations
19.
20.
Zhu, Jundong, Chao Liang, Yibo Hua, et al.. (2017). The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma. Oncotarget. 8(31). 51559–51568. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shifeng Su Breakdown of academic impact, for papers by Bong Ryoul Oh Breakdown of academic impact, for papers by Charlotte Hill Breakdown of academic impact, for papers by Marialaura Petroni Breakdown of academic impact, for papers by Yoko Ino Breakdown of academic impact, for papers by Wei Cang Breakdown of academic impact, for papers by Shigenori Furukawa Breakdown of academic impact, for papers by Roubini Zakopoulou Breakdown of academic impact, for papers by Zhaolei Cui Breakdown of academic impact, for papers by F. Alameda
Rankless by CCL
2026